1. Berge-Seidl, Victoria, Pihlstrøm, Lasse, Wszolek, Zbigniew K, Ross, Owen A, Toft, Mathias. 2018. No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease. In Neurobiology of aging, 74, 236.e1-236.e5. doi:10.1016/j.neurobiolaging.2018.09.022. https://pubmed.ncbi.nlm.nih.gov/30340792/
2. Kaur, Gurcharan, Pippin, James A, Chang, Solomon, Hankenson, Kurt D, Wagley, Yadav. 2024. Osteoporosis GWAS-implicated DNM3 locus contextually regulates osteoblastic and chondrogenic fate of mesenchymal stem/progenitor cells through oscillating miR-199a-5p levels. In JBMR plus, 8, ziae051. doi:10.1093/jbmrpl/ziae051. https://pubmed.ncbi.nlm.nih.gov/38686038/
3. Wang, Wenjing, Gilligan, Diana M, Sun, Sijie, Wu, Xiaoping, Reems, Jo-Anna. 2011. Distinct functional effects for dynamin 3 during megakaryocytopoiesis. In Stem cells and development, 20, 2139-51. doi:10.1089/scd.2011.0159. https://pubmed.ncbi.nlm.nih.gov/21671749/
4. Jiang, Liang, Liang, Qi-Lian, Liang, Wei-Ming, Huang, Zhi-Gang, Zhang, Xiang-Ning. 2018. Construction of a recombinant eukaryotic expression vector containing DNM3 gene and its expression in colon cancer cells. In OncoTargets and therapy, 11, 6665-6671. doi:10.2147/OTT.S176388. https://pubmed.ncbi.nlm.nih.gov/30349300/
5. Zhang, Zhengdong, Chen, Chun, Guo, Weike, Sun, Zhenghua, Geng, Xiaoping. 2016. DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53. In Medical science monitor : international medical journal of experimental and clinical research, 22, 197-205. doi:. https://pubmed.ncbi.nlm.nih.gov/26784388/
智鼠故事 
